Buscar resultados de ensayos clínicos
Lymphoma, Extranodal NK-T-Cell - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas Condición:
Fecha: 2016-08-04 Intervenciones: |
Recruiting |
Nombre del estudio: VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT) Condición: Extranodal NK-T-Cell Lymphoma Fecha: 2015-09-06 Intervenciones:
|
Terminated |
Nombre del estudio: Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma Condición: Extranodal NK-T-CELL LYMPHOMA Fecha: 2016-06-09 Intervenciones:
|
Recruiting |
Nombre del estudio: Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients Condición: Extranodal NK-T-Cell Lymphoma, Nasal Type Fecha: 2017-03-09 Intervenciones: Combination Product: L-Asparaginase or or Pegaspargase containing chemotherapy Patients receive at least |
Recruiting |
Nombre del estudio: MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma Condición: Extranodal NK-T-Cell Lymphoma, Nasal Type Fecha: 2016-04-29 Intervenciones:
|
Recruiting |
Nombre del estudio: GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma Condición: Extranodal NK-T-Cell Lymphoma, Nasal Type Fecha: 2016-04-05 Intervenciones:
|
Recruiting |
Nombre del estudio: PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma Condición: Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Fecha: 2014-03-11 Intervenciones:
|
Completed |
Nombre del estudio: Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma Condición: Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Fecha: 2010-09-08 Intervenciones: Radiation: CCRT+MIDLE chemotherapy Patients are planned to be treated with CCRT plus MIDLE chemotherapy |
Completed |
Nombre del estudio: Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell Lymphoma Condición: Peripheral T/NK-cell Lymphoma Fecha: 2010-08-30 Intervenciones: Biological: KW-0761 Intravenously 8 times at 1-week intervals |
Recruiting |
Nombre del estudio: T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas Condición:
|